Back
Japan Medical Dynamic Marketing Vs. Nxera Pharma Industry Stock Comparison
Sell
44
JMDMF
Japan Medical Dynamic Marketing
Last Price:
5.19
Seasonality Move:
0%
Sell
22
SOLTF
Nxera Pharma
Last Price:
6.95
Seasonality Move:
17.26%
Sell
44
Japan Medical Dynamic Marketing (JMDMF)
is a Sell
Is Japan Medical Dynamic Marketing a Buy, Sell or Hold?
- The current Japan Medical Dynamic Marketing [JMDMF] share price is $5.19. The Score for JMDMF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- JMDMF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $6.95. The Score for SOLTF is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JMDMF Stock Price Chart
What is Japan Medical Dynamic Marketing's stock price today?
-
The Japan Medical Dynamic Marketing share price today is $5.19
The current trend is relatively stagnant and JMDMF is experiencing slight buying pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $6.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
JMDMF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.19 - 5.19) | Sell |
Bollinger Bands (100): | (4.11 - 10.07) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 18.38 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.39 - 8.13) | Sell |
Bollinger Bands (100): | (7.64 - 9.74) | Sell |
JMDMF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.19 | Sell |
20-day SMA: | 5.19 | Sell |
50-day SMA: | 5.19 | Sell |
200-day SMA: | 9.42 | Sell |
8-day EMA: | 5.19 | Sell |
20-day EMA: | 5.2 | Sell |
50-day EMA: | 5.57 | Sell |
200-day EMA: | 8.42 | Sell |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.3 | Sell |
20-day SMA: | 7.72 | Sell |
50-day SMA: | 7.9 | Sell |
200-day SMA: | 9.3 | Sell |
8-day EMA: | 7.29 | Sell |
20-day EMA: | 7.56 | Sell |
50-day EMA: | 7.94 | Sell |
200-day EMA: | 9.15 | Sell |
Japan Medical Dynamic Marketing Earnings Growth & JMDMF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Japan Medical Dynamic Marketing Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |